Executives On The Move: New Hires In Science, Sales And Finance At Halozyme, Akebia And Medivir
Executive Summary
Oncology pharmaco Halozyme to bring on SVP, R&D, and kidney disease treatment firm Akebia Therapeutics taps a Biogen SVP as chief commercial officer. Also, Swiss biotech Medivir announces change in CFO to come in summer.